Ownership history in UBS Group AG · 8 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in MURAL ONCOLOGY PUB LTD CO (MURA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 445 | -4,861 | -91.6% | 0.00% | $921 | — |
| 2025 Q2 | REDUCED | 5,306 | -101,002 | -95.0% | 0.00% | $13K | — |
| 2025 Q1 | ADDED | 106,308 | +104,372 | +5391.1% | 0.00% | $134K | — |
| 2024 Q4 | ADDED | 1,936 | +1,251 | +182.6% | 0.00% | $6K | — |
| 2024 Q3 | REDUCED | 685 | -19,267 | -96.6% | 0.00% | $2K | — |
| 2024 Q2 | REDUCED | 19,952 | -421 | -2.1% | 0.00% | $63K | — |
| 2024 Q1 | ADDED | 20,373 | +7,055 | +53.0% | 0.00% | $100K | — |
| 2023 Q4 | INITIATED | 13,318 | — | — | 0.00% | $79K | — |
As of 2025 Q3 — sorted by position size